AnaBios: Funding, Investors & Team (Sep 2026)
AnaBios works in empowering human-centered drug disclosure. As a CRO, AnaBios gives items and administrations to each phase of medication revelation. Through restrictive innovation in light of the utilization of human benefactor organs and tissues, it concentrates on ex vivo human reactions to drugs and further research the sub-atomic and useful premise of applicable human physiology. Its exploration centers essentially around the areas of high, neglected clinical need, including heart illness and wellbeing, torment, PKD kidney sickness, and neurodegeneration. In association with Fortune 500 drug organizations, contract research associations, and colleges, the organization's central goal is to foster restorative progressions to assist patients with living longer, better, and more useful lives.
AnaBios has raised $6.5M across 1 funding round on record, the most recent a Private Equity of $6.5M announced in Jun 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AnaBios Company Profile and Key Stats
Latest funding round on record: Jun 2022.
AnaBios Funding Rounds
AnaBios Founders and Leadership Team
Contact details for the AnaBios team: 1 of 1 has an email address on file.
Start 14-day free trial →AnaBios Funding Compared to Other Biotechnology Startups
AnaBios' latest round of $6.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AnaBios in Biotechnology and San Diego
Companies Similar to AnaBios
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
AnaBios Funding FAQs
What does AnaBios do?
AnaBios works in empowering human-centered drug disclosure. As a CRO, AnaBios gives items and administrations to each phase of medication revelation. Through restrictive innovation in light of the utilization of human benefactor organs and tissues, it concentrates on ex vivo human reactions to drugs and further research the sub-atomic and useful premise of applicable human physiology. Its exploration centers essentially around the areas of high, neglected clinical need, including heart illness and wellbeing, torment, PKD kidney sickness, and neurodegeneration. In association with Fortune 500 drug organizations, contract research associations, and colleges, the organization's central goal is to foster restorative progressions to assist patients with living longer, better, and more useful lives.
How much funding has AnaBios raised?
AnaBios has raised $6.5M across 1 round on record. The most recent is a Private Equity of $6.5M announced in Jun 2022.
When did AnaBios last raise funding?
AnaBios' most recent funding round on record is a Private Equity of $6.5M, announced in Jun 2022.
Who founded AnaBios?
FundedIQ lists Paul Miller (Founder) at AnaBios.
Where is AnaBios headquartered?
AnaBios is based in San Diego, California, United States.
How many employees does AnaBios have?
AnaBios is in the 11-50 employee band.
How does AnaBios' funding compare to other Biotechnology startups?
AnaBios' latest round of $6.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's AnaBios Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AnaBios is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.